Ridgetech (FRA:7QL) PE Ratio without NRI: At Loss (As of Jul. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:7QL Ridgetech Inc FRA:7QL
40 GF Score
Price €20,304.00
GF Value €2,118,249.18
! 5 Warning Signs
View Full Analysis

What is Ridgetech PE Ratio without NRI?

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-07-25), Ridgetech's share price is €20304.00. Ridgetech's EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2025 was €-50.41. Therefore, Ridgetech's PE Ratio without NRI for today is At Loss.

During the past 13 years, Ridgetech's highest PE Ratio without NRI was 6.27. The lowest was 0.00. And the median was 3.86.

Ridgetech's EPS without NRI for the six months ended in Sep. 2025 was €-1.31. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2025 was €-50.41.

As of today (2026-07-25), Ridgetech's share price is €20304.00. Ridgetech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 was €312.30. Therefore, Ridgetech's PE Ratio (TTM) for today is 65.02.

During the past years, Ridgetech's highest PE Ratio (TTM) was 2.34. The lowest was 0.00. And the median was 0.67.

Ridgetech's EPS (Diluted) for the six months ended in Sep. 2025 was €-1.28. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 was €312.30.

Ridgetech's EPS (Basic) for the six months ended in Sep. 2025 was €-1.28. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2025 was €312.30.


Ridgetech  (FRA:7QL) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


Ridgetech PE Ratio without NRI Related Terms


Ridgetech PE Ratio without NRI Historical Data

* Premium members only.

The historical data trend for Ridgetech's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ridgetech PE Ratio without NRI Chart

Ridgetech Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
PE Ratio without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only At Loss At Loss At Loss 6.27 At Loss

Ridgetech Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
PE Ratio without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss 6.27 At Loss At Loss At Loss

FRA:7QL vs DHTI, PMHS, BLMH: PE Ratio without NRI Comparison

For the Pharmaceutical Retailers subindustry, Ridgetech's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ridgetech PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ridgetech's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Ridgetech's PE Ratio without NRI falls into.


FRA:7QL
40GF Score
Ridgetech Inc FRA:7QL
PE Ratio without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ridgetech PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

Ridgetech's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=20304.00/-50.405
=-402.82(At Loss)

Ridgetech's Share Price of today is €20304.00.
For company reported semi-annually, Ridgetech's EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-50.41.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Is Ridgetech (FRA:7QL) Overvalued in 2026?

Based on GuruFocus' analysis, Ridgetech stock appears to be undervalued. The current stock price of €20,304.00 is trading 99% below its estimated GF Value™ of €2,118,249.18.

Key valuation signals for FRA:7QL:

  • PE Ratio without NRI: At Loss
  • GF Value™: €2,118,249.18 vs. price of €20,304.00 (99% below fair value)
  • GF Score™: 40/100 with 5 warning signs

No single metric tells the full story. See the FRA:7QL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ridgetech Business Description

Other Exchanges RDGT:USA
Address 18th Street, 5th Floor, Building 6, No. 100, Baiyang Sub-district, Qiantang District, Zhejiang Province, Hangzhou, CHN, 310008
Ridgetech Inc formerly China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products. The company's operating segments include Retail drugstores, Online Pharmacy, and Drug wholesale. Retail drugstores segment sells prescription and over-the-counter medicines, TCM, dietary supplements, medical devices, and sundry items to retail customers. The online pharmacy segment sells drugs through third-party platforms such as Alibaba's Tmall, JD.com, and Amazon.com. It generates maximum revenue from the Retail drugstores segment.
40GF Score

Get the complete analysis for FRA:7QL

PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20,304.00
Price
€2,118,249.18
GF Value